U.S. FDA Drug and Product Approvals Document List
Updated/Revised Date: 2022-04-13
Summary: Archive of published articles and documents from the Disabled World FDA News and Approvals category. Although some of these documents may have since been updated, re-written, replaced, or revised, they are sorted below by their original publish date. The most recent publications are listed at the top of the table with older articles being listed in descending order by the date they were created.
You can also receive our latest related publications by subscribing to our FDA News and Approvals RSS feed.
FDA News and Approvals Publications - (71 Articles)
Cognoa ASD Diagnosis Aid Approved for Marketing by FDA
Cognoa ASD Diagnosis Aid is an aid for diagnosis of ASD in patients 18 months - 5 years of age who are at risk of developmental delay based on concerns of a parent, caregiver, or health care provider.
Author: U.S. Food and Drug Administration
Publish Date: 2021-06-03 - Updated: 2022-01-03Neurolutions IpsiHand Upper Extremity Rehabilitation System
U.S. FDA authorizes marketing of Neurolutions IpsiHand Upper Extremity Rehabilitation System to facilitate muscle rehabilitation in stroke patients.
Author: U.S. Food and Drug Administration
Publish Date: 2021-04-24 - Updated: 2022-01-03Safety and Effectiveness of Consumer Hand Sanitizers
U.S. FDA completes series of actions on review of OTC antiseptic active ingredients and issues final rule on safety and effectiveness of consumer hand sanitizers.
Author: U.S. Food and Drug Administration
Publish Date: 2019-04-11 - Updated: 2020-03-21Generic Version of EpiPen Approved by U.S. FDA
Teva Pharmaceuticals USA gains approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths for emergency treatment of allergic reactions in adults and pediatric patients who weigh more than 33 pounds.
Author: U.S. Food and Drug Administration
Publish Date: 2018-08-19Scammers Target Consumers with Fake FDA Warning Letters
U.S. FDA warns consumers about criminals forging FDA warning letters to target people who tried to purchase medicines online or over the phone.
Author: U.S. Food and Drug Administration
Publish Date: 2018-07-13 - Updated: 2019-04-30FDA Approves Glucose Monitoring System with Sensor and App for Adults with Diabetes
FDA approves continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes.
Author: U.S. Food and Drug Administration (FDA)
Publish Date: 2018-06-21 - Updated: 2019-02-08Automated Insulin Delivery and Monitoring System for Younger Pediatric Patients Approved by FDA
FDA approval of MiniMed 670G hybrid closed looped diabetes device to automatically monitor glucose and provide appropriate basal insulin doses for individuals aged 7 to 13 with type 1 diabetes.
Author: U.S. Food and Drug Administration (FDA)
Publish Date: 2018-06-21 - Updated: 2019-02-08US FDA Authorizes First Fully Interoperable Continuous Glucose Monitoring System
US FDA has permitted marketing of Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose levels in children aged 2 and older and adults with diabetes.
Author: U.S. Food and Drug Administration
Publish Date: 2018-03-29Statement From FDA Commissioner on Steps to Facilitate Efficient Generic Drug Review to Enhance Competition, Promote Access and Lower Drug Prices
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices.
Author: U.S. FDA
Publish Date: 2018-01-03 - Updated: 2018-03-15FDA Permits Marketing of Device to Treat Diabetic Foot Ulcers
U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
Author: U.S. Food and Drug Administration
Publish Date: 2017-12-28 - Updated: 2018-03-15U.S. FDA Approves Gene Therapy for Treatment of Cancer and Life-threatening Diseases
FDA approval brings first gene therapy to the United States with CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia.
Author: U.S. Food and Drug Administration
Publish Date: 2017-09-22 - Updated: 2017-09-27U.S. FDA Approves Radicava (Edaravone) to Treat ALS
U.S. Food and Drug Administration approves Radicava (edaravone) to treat amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.
Author: U.S. Food and Drug Administration
Publish Date: 2017-05-06U.S. FDA Approves Ocrevus (Ocrelizumab) to Treat Multiple Sclerosis
Ocrevus (ocrelizumab) has been approved to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).
Author: U.S. Food and Drug Administration (FDA)
Publish Date: 2017-03-30Researchers Urge More Transparency From FDA
Researchers create Blueprint for Transparency to advance the development of safe and effective new products.
Author: Johns Hopkins University Bloomberg School of Public Health
Publish Date: 2017-03-18FDA Approves Noctiva for Frequent Night Urination Treatment
Noctiva, desmopressin acetate, is a nasal spray for adults who awaken during the night to urinate (nocturnal polyuria).
Author: U.S. Food and Drug Administration
Publish Date: 2017-03-07FDA Approves Emflaza (Deflazacort) to Treat Duchenne Muscular Dystrophy
Food and Drug Administration approves Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy.
Author: U.S. Food and Drug Administration (FDA)
Publish Date: 2017-02-09Lawsuit Urges FDA to Protect Hair Salon Workers and Consumers from Formaldehyde
Lawsuit claims U.S. FDA failed to adequately respond to concerns raised about health risks salon keratin hair products containing formaldehyde pose.
Author: Environmental Working Group
Publish Date: 2016-12-14FDA Approves First Drug to Treat Duchenne Muscular Dystrophy
U.S. Food and Drug Administration approves Exondys 51 (eteplirsen) injection to treat patients with Duchenne muscular dystrophy (DMD).
Author: U.S. FDA
Publish Date: 2016-09-20FDA Challenged to Support Claims Regarding Electronic Cigarettes
Advocates such as E Cigarette Reviewed calling on US FDA to take evidence based approach to electronic cigarette technology.
Author: E-Cigarette Reviewed
Publish Date: 2013-02-20Ethical Dilemmas Contribute to Weakness in FDA Postmarket Oversight
Institute of Medicine (IOM) report recommendations for maintaining delicate balance of drug innovation and drug safety.
Author: Johns Hopkins Medicine
Publish Date: 2012-08-23 - Updated: 2021-08-05Insomnia Drug Intermezzo Approved by FDA
US FDA approves Intermezzo zolpidem tartrate sublingual tablets for insomnia characterized by night waking followed by difficulty returning to sleep.
Author: U.S. Food and Drug Administration
Publish Date: 2011-11-25Cialis to Treat Benign Prostatic Hyperplasia Approved by FDA
US FDA approves Cialis tadalafil to treat signs and symptoms of benign prostatic hyperplasia BPH and for treatment of erectile dysfunction ED when the conditions occur simultaneously.
Author: U.S. Food and Drug Administration
Publish Date: 2011-10-13Boostrix for Tetanus, Diphtheria and Pertussis in Seniors
U.S. Food and Drug Administration approves Boostrix vaccine to prevent tetanus diphtheria and pertussis (whooping cough) in people ages 65 and older.
Author: U.S. Food and Drug Administration
Publish Date: 2011-07-10FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain
FDA approved Lazanda (fentanyl) nasal spray for management of breakthrough pain in cancer patients 18 years and older already receiving and are tolerant to opioid therapy for underlying persistent cancer pain.
Author: Archimedes Pharma Ltd.
Publish Date: 2011-06-30Global Strategy to Help Ensure Safety and Quality of Imported Products
The FDA Pathway to Global Product Safety and Quality strategy to meet challenges posed by rapidly rising imports of FDA regulated products and complex global supply chain.
Author: U.S. Food and Drug Administration
Publish Date: 2011-06-20Injectable Gel to Treat Fecal Incontinence Approved by FDA
Sterile injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change fiber therapy or anti-motility medications failed.
Author: U.S. Food and Drug Administration
Publish Date: 2011-05-28Toxoplasmosis Parasite Infection Test
Toxoplasmosis is caused by the parasite Toxoplasma gondii and can cause serious health problems in people with compromised immune systems.
Author: U.S. Food and Drug Administration
Publish Date: 2011-05-24 - Updated: 2019-01-16Sutent for Rare Type of Pancreatic Cancer Approved by FDA
Sutent (sunitinib) approved for progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or have spread to other parts of the body.
Author: U.S. Food and Drug Administration
Publish Date: 2011-05-22Q Fever Test for Military Serving Overseas
Q fever is an infectious disease among serving soldiers and can cause acute or chronic illness after contact with infected animals or exposure to contaminated environments.
Author: U.S. Food and Drug Administration
Publish Date: 2011-05-22 - Updated: 2022-03-28Edurant FDA Approved HIV Treatment
The U.S. Food and Drug Administration has approved Edurant (rilpivirine) in combination with other anti-retroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy.
Author: U.S. Food and Drug Administration
Publish Date: 2011-05-20 - Updated: 2022-03-29FDA Approves Victrelis for Hepatitis C
The safety and effectiveness of Victrelis was evaluated in two phase 3 clinical trials with 1500 adult patients.
Author: U.S. Food and Drug Administration
Publish Date: 2011-05-14FDA Approves Tradjenta (linagliptin) for Treatment of Type 2 Diabetes
U.S. Food and Drug Administration has approved Tradjenta (linagliptin) tablets a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.
Author: FDA Approvals
Publish Date: 2011-05-03Horizant for Restless Legs Syndrome FDA Approved
FDA approved drug Horizant provides significant help in treating restless legs syndrome symptoms.
Author: U.S. Food and Drug Administration
Publish Date: 2011-04-10FDA Proposes Draft Menu and Vending Machine Labeling Requirements
Calorie labeling on menus and menu boards in chain restaurants retail food establishments and vending machines.
Author: U.S. Food and Drug Administration
Publish Date: 2011-04-01Yervoy Ipilimumab Treatment for Late Stage Skin Cancer
U.S. Food and Drug Administration (FDA) approves Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer.
Author: U.S. Food and Drug Administration
Publish Date: 2011-03-28 - Updated: 2022-05-02Zostavax Vaccine to Prevent Shingles - FDA Approval
FDA approves Zostavax a live attenuated virus vaccine for the prevention of shingles in individuals 50 to 59 years of age.
Author: U.S. Food and Drug Administration
Publish Date: 2011-03-25FDA Approves Edarbi for High Blood Pressure
Data from clinical studies showed Edarbi tablets (azilsartan medoxomil) to be more effective in lowering 24-hour blood pressure compared with two other FDA-approved hypertension drugs.
Author: U.S. Food and Drug Administration
Publish Date: 2011-02-26 - Updated: 2022-05-22Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Congress passed the Orphan Drug Act because it recognized that adequate drugs for many rare diseases have not been developed.
Author: Neuralstem, Inc.
Publish Date: 2011-02-14FDA Approves Viibryd to Treat Major Depressive Disorder
FDA approves Viibryd tablets (vilazodone hydrochloride) to treat major depressive disorder in adults.
Author: U.S. Food and Drug Administration
Publish Date: 2011-01-22Natroba (Spinosad) Head Lice Treatment for Children and Adults - FDA Approval
Natroba provides another option for the topical treatment of head lice infestations.
Author: U.S. Food and Drug Administration
Publish Date: 2011-01-18FDA Warns Consumers Not to Use Fruta Planta Weight Loss Products
The FDA has received multiple reports of adverse events associated with the use of Fruta Planta and Reduce Weight Fruta Planta.
Author: FDA
Publish Date: 2011-01-01FDA Approval for Axiron (testosterone) Topical Solution CIII
Axiron topical solution CIII for replacement therapy in men for certain conditions associated with a deficiency or absence of testosterone.
Author: Health News
Publish Date: 2010-11-27 - Updated: 2016-06-13Extension of FDA Review for Cladribine Tablets for Treatment of Relapsing Forms of Multiple Sclerosis
EMD Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis.
Author: EMD Serono, Inc.
Publish Date: 2010-11-26 - Updated: 2017-02-13FDA Approves Cymbalta for Chronic Musculoskeletal Pain
Cymbalta a non-narcotic pain reliever has shown to significantly reduce chronic low back pain and chronic pain due to osteoarthritis.
Author: Eli Lilly and Company
Publish Date: 2010-11-07FDA Approval of First Drug to Treat Tuberous Sclerosis Complex
Tuberous Sclerosis Alliance Announces FDA Approval of First Drug to Treat Tuberous Sclerosis Complex.
Author: Tuberous Sclerosis Alliance
Publish Date: 2010-10-30 - Updated: 2017-06-26PRADAX Approved for for Stroke Prevention in Canadians with Atrial Fibrillation
PRADAX is an alternative for Canadians at high risk of stroke due to atrial fibrillation.
Author: BOEHRINGER INGELHEIM
Publish Date: 2010-10-27New Oral Contraceptive Also Raises Folate Levels
Beyaz is the first and only OC approved to raise folate levels in women who choose an OC for birth control.
Author: Bayer HealthCare Pharmaceuticals Inc.
Publish Date: 2010-09-25Oral Drug to Reduce MS Relapses FDA Approved
FDA has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).
Author: U.S. Food and Drug Administration
Publish Date: 2010-09-22FDA Approves New Drug for Gout
FDA approves Krystexxa (pegloticase) to treat gout in adults who do not respond to or who cannot tolerate conventional therapy.
Author: U.S. Food and Drug Administration
Publish Date: 2010-09-15FDA Approves Pediatric Use of Chemical Poisoning Treatment
The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride.
Author: U.S. Food and Drug Administration
Publish Date: 2010-09-09Actavis Receives FDA Approval of Atomoxetine HCl Capsules for ADHD
Actavis receives approval from FDA to market Atomoxetine HCl capsules for treatment of attention deficit hyperactivity disorder (ADHD).
Author: Actavis Inc.
Publish Date: 2010-09-02FDA Approves New Abortion Drug Ella as Emergency Contraceptive
Ella is a drug that can cause abortions but is misleadingly labeled as an effective Emergency Contraceptive.
Author: Family Research Council
Publish Date: 2010-08-15Public Outcry for FDA Reform
A rise in undisclosed side-effects of prescription medications like Vioxx and Avandia have put the U.S. FDA under fire with consumer watch groups calling for agency reform.
Author: Disabled World
Publish Date: 2010-08-13 - Updated: 2022-03-22FDA Approves Vaccines for 2010-2011 Influenza Season
US FDA has approved vaccines for the 2010-2011 influenza season in the United States including H1N1.
Author: U.S. Food and Drug Administration
Publish Date: 2010-07-31New York State Approves Quest Diagnostics Fragile X Syndrome Test
XSense laboratory test that may be suitable for population-based screening for Fragile X Syndrome.
Author: Quest Diagnostics
Publish Date: 2010-07-30Implantable Miniature Telescope Improves Sight of AMD Patients
FDA has approved Implantable Miniature Telescope (IMT) to improve vision in patients with age-related macular degeneration (AMD).
Author: U.S. Food and Drug Administration
Publish Date: 2010-07-08Circadin Approved in EU for Treatment of Primary Insomnia
Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months.
Author: Neurim Pharmaceuticals LTD
Publish Date: 2010-07-05FDA Approves New Treatment for Advanced Prostate Cancer
Jevtana (cabazitaxel) chemotherapy drug used in combination with steroid prednisone to treat prostate cancer.
Author: U.S. Food and Drug Administration
Publish Date: 2010-06-18FDA Clearance of Lactate Test
FDA clearance to market new lactate test on the epoc Blood Analysis System.
Author: Epocal, Inc.
Publish Date: 2010-06-15FDA Advisory Committee Recommends Approval of FTY720 Fingolimod for Relapsing Remitting Multiple Sclerosis
FTY720 (fingolimod) represents significant advance as efficacious MS oral treatment for people with relapsing remitting multiple sclerosis.
Author: Novartis Pharmaceuticals Corporation
Publish Date: 2010-06-12FDA to Review Dental Amalgam
Dental amalgam is a mixture of metals composed of liquid mercury powdered amalgam alloy composed primarily of silver tin, and copper.
Author: U.S. Food and Drug Administration
Publish Date: 2010-06-10FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women
Injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.
Author: U.S. Food and Drug Administration
Publish Date: 2010-06-01LensAR Laser System Receives FDA Clearance for Use in Cataract Surgery
Clearance from the FDA for use of the LensAR Laser System for anterior capsulotomy during cataract surgery.
Author: LensAR, Inc.
Publish Date: 2010-05-18FDA Clearance for Redsense Safety Device for Home use During Home Hemodialysis
Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis.
Author: Redsense Medical AB
Publish Date: 2010-05-18Equal Rigor in Assessing Food Claims and Drug Approvals
Iom report recommends framework to evaluate science behind health claims for foods and drugs equal rigor in assessing food claims and drug approvals.
Author: DW
Publish Date: 2010-05-12U.S. FDA Approves Natazia, a New Oral Contraceptive for the Prevention of Pregnancy
Introducing the first and only oral contraceptive to bring estradiol valerate together with dienogest in a new dosing regimen.
Author: Bayer HealthCare Pharmaceuticals Inc.
Publish Date: 2010-05-08FDA Approved VIMOVO for Arthritis Patients
New treatment option for the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Author: FDA Approvals
Publish Date: 2010-05-03 - Updated: 2018-01-26FDA Approval of Asclera to Treat Varicose Veins
Approval of Asclera (polidocanol) Injection a sclerotherapy treatment for uncomplicated spider and reticular veins.
Author: Merz Aesthetics
Publish Date: 2010-04-24 - Updated: 2010-05-29Device Manufacturers to Include Information on Pediatric Populations
Requirement that device manufacturers provide readily available information in certain premarket applications on pediatric patients.
Author: U.S. Food and Drug Administration
Publish Date: 2010-03-31Once-Daily MIRAPEX ER Approved by FDA for Parkinson's Disease
Increased hours during which people with Parkinsons disease have better mobility.
Author: Boehringer Ingelheim Pharmaceuticals, Inc.
Publish Date: 2010-03-23FDA Approval of Differin (adapalene) Lotion for Acne Treatment
Lotion formulation of the well-tolerated retinoid adapalene for the treatment of acne.
Author: Galderma Laboratories, L.P.
Publish Date: 2010-03-22 - Updated: 2010-06-25
You're reading Disabled World. See our homepage for informative disability news, reviews, sports, stories and how-tos. You can also connect with us on Twitter and Facebook or learn more about Disabled World on our about us page.
Disabled World provides general information only. The materials presented are never meant to substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Financial support is derived from advertisements or referral programs, where indicated. Any 3rd party offering or advertising does not constitute an endorsement.
• Cite This Page (APA): Disabled World. (2022, April 13). U.S. FDA Drug and Product Approvals. Disabled World. Retrieved December 1, 2022 from www.disabled-world.com/medical/pharmaceutical/fda-2/
• Permalink: <a href="https://www.disabled-world.com/medical/pharmaceutical/fda-2/">U.S. FDA Drug and Product Approvals Articles</a>